EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases

Yue Wu, Xin Li, Xueyu Fu, Xiaomin Huang, Shenrong Zhang, Nan Zhao, Xiaowei Ma, Qimanguli Saiding, Mei Yang, Wei Tao, Xingtao Zhou, Jinhai Huang iD

Advanced Science · 2024-08 · 11 (32)

DOI: 10.1002/advs.202403399 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 21.06.2024. Verfasst von Yue Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University; NHC Key Laboratory of Myopia and Related Eye Diseases; Key Labor…. Hauptthemen laut MEDLINE: Drug Delivery Systems, Eye Diseases. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Nature Science Foundation of China, Project of Shanghai Science and Technology, EYE & ENT Hospital of Fudan University High-level Talents Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Funduscopic diseases, including diabetic retinopathy (DR) and age‐related macular degeneration (AMD), significantly impact global visual health, leading to impaired vision and irreversible blindness. Delivering drugs to the posterior segment of the eye remains a challenge due to the presence of multiple physiological and anatomical barriers. Conventional drug delivery methods often prove ineffective and may cause side effects. Nanomaterials, characterized by their small size, large surface area, tunable properties, and biocompatibility, enhance the permeability, stability, and targeting of drugs. Ocular nanomaterials encompass a wide range, including lipid nanomaterials, polymer nanomaterials, metal nanomaterials, carbon nanomaterials, quantum dot nanomaterials, and so on. These innovative materials, often combined with hydrogels and exosomes, are engineered to address multiple mechanisms, including macrophage polarization, reactive oxygen species (ROS) scavenging, and anti‐vascular endothelial growth factor (VEGF). Compared to conventional modalities, nanomedicines achieve regulated and sustained delivery, reduced administration frequency, prolonged drug action, and minimized side effects. This study delves into the obstacles encountered in drug delivery to the posterior segment and highlights the progress facilitated by nanomedicine. Prospectively, these findings pave the way for next‐generation ocular drug delivery systems and deeper clinical research, aiming to refine treatments, alleviate the burden on patients, and ultimately improve visual health globally.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Delivery SystemsEye DiseasesHumansNanotechnologyPosterior Eye SegmentAnimalsNanomedicineNanostructuresDiabetic Retinopathy

Stichwörter der Autor:innen

ROS scavenginganti‐VEGF therapydrug deliverynanomedicineposterior segment ocular diseases

Autor:innen und Institutionen

  • Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University; NHC Key Laboratory of Myopia and Related Eye Diseases; Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical S…
  • Shanghai Research Center of Ophthalmology and Optometry, Shanghai, 200031, China.
  • Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
  • Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.

ORCID-Profile: Jinhai Huang

Förderung

  • National Nature Science Foundation of China
  • Project of Shanghai Science and Technology
  • EYE & ENT Hospital of Fudan University High-level Talents Program
  • Medical Engineering fund of Fudan University
  • Postdoctoral Science Foundation of China
  • Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning;
  • National Natural Science Foundation of China

Zitieren

APA

Wu, Y., Li, X., Fu, X., Huang, X., Zhang, S., Zhao, N., Ma, X., Saiding, Q., Yang, M., Tao, W., Zhou, X., & Huang, J. (2024). Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases. Advanced Science, 11(32). https://doi.org/10.1002/advs.202403399

Vancouver

Wu Y, Li X, Fu X, Huang X, Zhang S, Zhao N, et al. Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases. Advanced Science. 2024;11(32). doi:10.1002/advs.202403399

BibTeX
@article{Wu2024,
  author = {Wu, Yue and Li, Xin and Fu, Xueyu and Huang, Xiaomin and Zhang, Shenrong and Zhao, Nan and Ma, Xiaowei and Saiding, Qimanguli and Yang, Mei and Tao, Wei and Zhou, Xingtao and Huang, Jinhai},
  title = {Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {32},
  doi = {10.1002/advs.202403399}
}
Kostenlos starten →